Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
Recruiting
N/A
Interventional Study
Lung Neoplasm
Thoracic Surgical Procedures
Perioperative Care
Postoperative Rehabilitation
Aged
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- Peking University People's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter prospective clinical study focuses on elderly patients with lung cancer. The investigators will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens, construct multidisciplinary perioperative comprehensive therapy, integrated Chinese-Western medicine full-cycle manage…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged ≥65 years old
2. Pathologically confirmed non-small cell lung cancer with clinical stage eligible for curative surgical resection
3. Complete preoperative geriatric comprehensive assessment data available
4. Capable of finishing planned surgery and long-term follow-up
5.…
Contacts
No contact information available.